News & Analysis on Clinical Trial Services & Contract Research And Development
MedImmune will soon ramp up production of its intranasal flu vaccine after the US Food and Drug Administration (FDA) approved its new and larger flu vaccine manufacturing facility in Speke, England.
Centocor has enlisted Cardinal Health to use its rapid cell line development technology to engineer cell lines expressing Centocor's monoclonal antibodies, and speed up the development of new biopharmaceuticals.
CFC International is to be acquired by Quad-C Management in a move that aims to capitalise on the worldwide demand for CFC International products that include hot stamp foils and heat transferable labels for intravenous solution bags, blood bags,...
EntreMed have entered into a new agreement with Elan, which allows the clinical-stage pharmaceutical company to utilise Elan's NanoCrystal Technology to develop the oncology product candidate, Panzem NCD.
Chromos has announced an expansion to an existing Pfizer collaboration, which builds on research focusing on genetic engineering of production cell lines with multiple genes to improve bioreactor performance and reduce monoclonal antibody (Mabs)...
Shimadzu make available the World's first network-enabled controller that allows web browser access of High Performance Liquid Chromatograph (HPLC) allowing laboratory researchers to control and monitor their Prominence and VP series HPLC systems.